Halozyme Therapeutics logo
Halozyme Therapeutics HALO
$ 49.38 8.05%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Halozyme Therapeutics DPO Ratio 2011-2024 | HALO

Annual DPO Ratio Halozyme Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
28 25.2 7.78 35.2 51.6 147 93.1 39.3 56.2 48.2 183 758 10.7 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
10.7 K 7.78 936

Quarterly DPO Ratio Halozyme Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
25.7 33.1 40.5 - 24.5 17.1 34.2 - 29.3 18.1 8.04 - 19.4 10.1 6.17 - 31.6 30.6 65.9 - 26.3 313 103 - 595 445 180 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
595 6.17 97.9